Literature DB >> 3792427

Femoxetine and cimetidine: interaction in healthy volunteers.

J Schmidt, A S Sørensen, A Gjerris, O J Rafaelsen, H Mengel.   

Abstract

The possibility of a pharmacokinetic interaction between femoxetine and cimetidine has been evaluated in 8 healthy volunteers. Two volunteers received single doses of femoxetine, and 6 were given multiple doses of femoxetine for 7 days with and without concurrent cimetidine. No influence of cimetidine was observed on the kinetics of single doses of femoxetine, but after multiple doses the plasma concentration of femoxetine was significantly increased. Similarly, the AUC at steady state tended to be increased, but not to a significant extent. Concurrent cimetidine did not cause a reduction in the AUC of the active desmethyl metabolite. It is recommended that femoxetine is given in reduced doses (e.g. 400 mg) when administered with cimetidine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792427     DOI: 10.1007/bf00981127

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics.

Authors:  J B Lassen; E Petersen; B Kjellberg; S O Olsson
Journal:  Eur J Pharmacol       Date:  1975-05       Impact factor: 4.432

2.  Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963.

Authors:  J B Lassen; R F Squires
Journal:  Neuropharmacology       Date:  1976-11       Impact factor: 5.250

3.  Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine.

Authors:  J B Lasen; R F Squires
Journal:  Neuropharmacology       Date:  1977 Jul-Aug       Impact factor: 5.250

4.  Determination of (+)-(3R), (4S)-3-[(4methoxyphenoxy)methyl]-1-methyl-4-phenylpiperidine hydrochloride (FG 4963) in biological fluids using competition for adsorption to glass.

Authors:  E Bechgaard; J Lund
Journal:  J Chromatogr       Date:  1977-03-11

5.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

6.  Cimetidine potentiation of the hypoprothrombinemic effect of warfarin.

Authors:  B A Silver; W R Bell
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

7.  Cimetidine-induced alterations in desipramine plasma concentrations.

Authors:  J D Amsterdam; D J Brunswick; L Potter; M J Kaplan
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Metabolism of femoxetine.

Authors:  H Larsson; J Lund
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-05

9.  Cimetidine interaction with imipramine and nortriptyline.

Authors:  S A Henauer; L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1984-02       Impact factor: 6.875

10.  Effects of cimetidine on caffeine disposition in smokers and nonsmokers.

Authors:  D C May; C H Jarboe; A B VanBakel; W M Williams
Journal:  Clin Pharmacol Ther       Date:  1982-05       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.